Cargando…
Assessment of Apolipoprotein(a) Isoform Size Using Phenotypic and Genotypic Methods
Apolipoprotein(a) (apo(a)) is the protein component that defines lipoprotein(a) (Lp(a)) particles and is encoded by the LPA gene. The apo(a) is extremely heterogeneous in size due to the copy number variations in the kringle-IV type 2 (KIV2) domains. In this review, we aim to discuss the role of gen...
Autores principales: | Fogacci, Federica, Di Micoli, Valentina, Avagimyan, Ashot, Giovannini, Marina, Imbalzano, Egidio, Cicero, Arrigo F. G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531419/ https://www.ncbi.nlm.nih.gov/pubmed/37762189 http://dx.doi.org/10.3390/ijms241813886 |
Ejemplares similares
-
Purine Metabolism Dysfunctions: Experimental Methods of Detection and Diagnostic Potential
por: Cicero, Arrigo F. G., et al.
Publicado: (2023) -
Management of High-Risk Hypercholesterolemic Patients and PCSK9 Inhibitors Reimbursement Policies: Data from a Cohort of Italian Hypercholesterolemic Outpatients
por: Fogacci, Federica, et al.
Publicado: (2022) -
Comparative effect of a nutraceutical compound based on a flavonoid complex from bergamot on plasma lipids, glucose metabolism, and liver enzymes: a 3-arm, double-blind, placebo-controlled, randomized clinical trial
por: Fogacci, Federica, et al.
Publicado: (2022) -
Sudden Fall in the Lipid-Lowering Effect of Evolocumab: The Butler Is Not Always Guilty
por: Fogacci, Federica, et al.
Publicado: (2021) -
Sudden Fall in the Lipid-Lowering Effect of Evolocumab: The Butler Is Not Always Guilty
por: Fogacci, Federica, et al.
Publicado: (2021)